Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 35
Phase 42

Trial Status

Completed11
Other1

Role Distribution

Principal Investigator9
Other Roles3
PI Rate75%

Activity Timeline

Clinical Trials (12)

NCT06446752Phase 3Active Not Recruiting
BIYELA - Bexsero Immunisation in Young Women in Africa
GonorrheaGonorrhea of AnusGonorrhea of Cervix+1 more
PrincipalinvestigatorStart date: 2024-08-14
NCT05388084Not ApplicableCompleted
Peer Led Outreach to Engage Male Partners of Pregnant Women in Uganda (Okutuuka Study)
Engagement, PatientHIV TestingLinkage to Care+1 more
PrincipalinvestigatorStart date: 2022-05-20
NCT04038060Not ApplicableCompleted
The PrEP (Pre-exposure Prophylaxis) SMART Study
HIV/AIDS
PrincipalinvestigatorStart date: 2019-05-16
NCT00076232Phase 3Completed
A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes
Herpes GenitalisHIV InfectionsHIV Seronegativity
Studychair
NCT00194519Phase 3Completed
Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission
Herpes Simplex, GenitalHIV InfectionSexually Transmitted Diseases
Principalinvestigator
NCT00378976Phase 3Completed
HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.
Herpes SimplexHIV InfectionSexually Transmitted Diseases
Principalinvestigator
NCT00465205Phase 3Completed
HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons
Herpes SimplexHIV InfectionsSexually Transmitted Diseases
Principalinvestigator

Showing 10 of 12 trials

Research Network

Collaboration Network

8 collaborators·8 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Anna Wald, MD, MPH

University of Washington

Very Similar
12 trials

Shared therapeutic areas:

Herpes GenitalisHIV InfectionsHerpes Simplex+3 more

Worked with same sponsors:

Bill and Melinda Gates FoundationEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)+8 more
Collaborated on 3 trials
Similarity Score72%

Jairam Lingappa, MD, PhD,

University of Washington

Moderately Similar
1 trials

Shared therapeutic areas:

Herpes GenitalisHIV InfectionsSexually Transmitted Diseases

Worked with same sponsors:

Bill and Melinda Gates FoundationUniversity of Washington
Collaborated on 1 trial
Similarity Score34%

Aldo Lucchetti, MD

Asociación Civil Impacta Salud y Educación, Lima, Peru

Related
1 trials

Shared therapeutic areas:

Herpesvirus 2, HumanHIV Infections

Worked with same sponsors:

Comprehensive International Program of Research on AIDSNational Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score24%

Sinead Delany-Moretlwe, MBChB, PhD

Wits Reproductive Health and HIV Institute

Related
1 trials

Shared therapeutic areas:

HIV/AIDS

Worked with same sponsors:

National Institute of Mental Health (NIMH)University of Washington+1 more
Collaborated on 1 trial
Similarity Score14%

Pablo Tebas, MD

University of Pennsylvania

Related
14 trials

Shared therapeutic areas:

HIV InfectionsHIV

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)National Institute of Mental Health (NIMH)+1 more
Similarity Score4%

François Raffi, PHD

Hopital Hotel Dieu Nantes

Related
1 trials

Shared therapeutic areas:

HIV Infections
Similarity Score2%

Gilles Pichancourt

CH Henri Duffaut Avignon

Related
1 trials

Shared therapeutic areas:

HIV Infections
Similarity Score2%

Bruno Marchou, PHD

CHU Purpan (Toulouse)

Related
1 trials

Shared therapeutic areas:

HIV Infections
Similarity Score2%

Jean Luc Schmit

Hôpital Nord Amiens

Related
1 trials

Shared therapeutic areas:

HIV Infections
Similarity Score2%

André Cabié

CHU Fort de France

Related
1 trials

Shared therapeutic areas:

HIV Infections
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (12)

Showing 12 of 12 trials

NCT06446752Phase 3PrincipalInvestigator

BIYELA - Bexsero Immunisation in Young Women in Africa

GonorrheaGonorrhea of AnusGonorrhea of Cervix+1 more
Active Not Recruiting
NCT05388084Not ApplicablePrincipalInvestigator

Peer Led Outreach to Engage Male Partners of Pregnant Women in Uganda (Okutuuka Study)

Engagement, PatientHIV TestingLinkage to Care+1 more
Completed
NCT04038060Not ApplicablePrincipalInvestigator

The PrEP (Pre-exposure Prophylaxis) SMART Study

HIV/AIDS
Completed
NCT02732730Phase 4StudyChair

Uptake and Adherence to Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study

HIV
Completed
NCT00076232Phase 3StudyChair

A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes

Herpes GenitalisHIV InfectionsHIV Seronegativity
Completed
NCT00194519Phase 3PrincipalInvestigator

Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission

Herpes Simplex, GenitalHIV InfectionSexually Transmitted Diseases
Completed
NCT00371592Phase 2StudyChair

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)

Herpesvirus 2, HumanHIV Infections
Completed
NCT00378976Phase 3PrincipalInvestigator

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.

Herpes SimplexHIV InfectionSexually Transmitted Diseases
Completed
NCT00465205Phase 3PrincipalInvestigator

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons

Herpes SimplexHIV InfectionsSexually Transmitted Diseases
Completed
NCT00808405Not ApplicablePrincipalInvestigator

GUD Clinical and Virologic Response to Acyclovir in HIV Negative African Women

Genital Herpes
Completed
NCT01026454Phase 4PrincipalInvestigator

Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons

HIV InfectionHSV Infection
Completed
NCT02038582Not ApplicablePrincipalInvestigator

Strategies to Increase HIV Testing, Linkages to Care, and Male Circumcision in Africa

HIV
Completed

All 12 trials loaded